丁信智DING, SHINN-JYH黃筠茹HUANG, YUN-RUYUN-RUHUANG口腔科學研究所博士班2026-01-092030-07-2420252025-07-22https://handle.ncl.edu.tw/11296/e5g7szhttps://scholars.csmu.edu.tw/handle/123456789/2899人口老化造成如骨質疏鬆症以及後續引發骨折治療等挑戰,為了解決此問題,諸多研究開發具促進造骨細胞分化與抑制蝕骨細胞成長的含鍶的骨移植,當中矽酸鍶(Strontium Silicate)生物陶瓷是具有應用潛力的材料,但其製程–結構–性質之間的關係仍缺乏深入研究。因此本研究探討矽酸鍶(SrSi)化學析出製程參數(NH4OH濃度與Sr/Si前驅物莫耳比),藉由調控組成與結構,對SrSi材料進行全面且系統性的分析以了解其性質。結果顯示,高濃度的NH4OH與較高的Sr/Si前驅物比有助於產生較小顆粒,提升SrSi比例,並促進SrSiO3與Sr2SiO4相的形成。20%氨水濃度及SrSi前驅物為比為1:4所合成的20NSr4組別無需額外添加分化因子即能促進hMSC的成骨分化,此外此材料有效抑制破骨細胞活性與誘導M2型巨噬細胞極化,及展現抗菌效應。除此之外,為深入探索其應用,將與高性能熱塑性聚碸(polysulfone; PSF)高分子混合製備成高強度複合材料,並比較四種不同矽烷偶合劑(Silanes)對其性能的影響。在四種矽烷處理(APE、APM、AEM、GPM)中,僅有APE改質後展現出顯著的機械性能提升。當5%APE改質SrSi與PSF後此複合材料(FSrAPE5)的壓縮強度與三點彎曲強度分別較純PSF提升42%與21%;拉伸與衝擊強度則無明顯變化。FSrAPE5改質後的複合材料其彈性模數由3.3 GPa提升至5.0 GPa。此外,FSrAPE組在體外降解測試中可維持穩定性達12個月。細胞行為表現上,FSrAPE組複合材能維持hMSC的成骨分化能力,有效抑制破骨細胞活性,並展現抗菌特性。整體而言,矽酸鍶具備良好的生物活性與抗菌能力,使其深具骨組織修補應用的材料。Population aging has led to increasing challenges such as osteoporosis and subsequent fracture treatments. To address these issues, various studies have focused on developing strontium-containing bone grafts that promote osteogenic differentiation and inhibit osteoclast activity. Among them, strontium silicate (SrSi)-based bioceramics have shown great potential; however, the relationship between their processing, structure, and properties remains insufficiently understood. Therefore, this study systematically investigates the chemical precipitation synthesis of SrSi by varying processing parameters, specifically the concentration of ammonium hydroxide (NH4OH) and the Sr/Si molar ratio of precursors. By tailoring the composition and structure, a comprehensive analysis of SrSi materials was conducted to understand their properties.The results indicate that higher NH4OH concentrations and increased Sr/Si precursor ratios promote the formation of smaller particles, enhance SrSi content, and favor the formation of SrSiO3 and Sr2SiO4 phases. Notably, 20NSr4 group synthesized with 20% ammonia concentration and a SrSi precursor molar ratio of 1:4. was able to induce osteogenic differentiation of human mesenchymal stem cells (hMSCs) without the addition of external differentiation factors. This material also effectively inhibited osteoclast activity, induced M2 macrophage polarization, and exhibited antibacterial activity. To further explore its application, SrSi was incorporated into a high-performance thermoplastic polymer polysulfone (PSF) to fabricate high-strength composites. The effects of four different silane coupling agents (APE, APM, AEM, and GPM) on composite performance were compared. Among them, only APE-treated SrSi significantly enhanced the mechanical properties of the composite. The FSrAPE5 composite (containing 5% APE-modified SrSi) showed improvements of 42% and 21% in compressive and three-point bending strength, respectively, compared to pure PSF, while tensile and impact strength remained largely unchanged. Moreover, the elastic modulus increased from 3.3 GPa to 5.0 GPa. In vitro degradation tests showed that FSrAPE composites maintained structural stability for up to 12 months. Regarding cellular behavior, FSrAPE composites retained the osteogenic potential of hMSCs, effectively suppressed osteoclast activity, and exhibited antibacterial properties. Overall, strontium silicate demonstrates favorable bioactivity and antibacterial capabilities, making it a promising candidate for bone tissue repair applications.矽酸鍶複合材矽烷偶合劑Strontium SilicateCompositeSilane coupling agent矽酸鍶的製程-結構-性質關係及其在骨組織應用潛力thesis